TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Operating Expenses Summary of TFBS Bioscience Inc.

  • TFBS Bioscience Inc.'s latest annual operating expenses in 2023 was 77.82 Million TWD , up 17.08% from previous year.
  • TFBS Bioscience Inc.'s latest quarterly operating expenses in 2023 FY was 82.28 Million TWD , up 17.08% from previous quarter.
  • TFBS Bioscience Inc. reported a annual operating expenses of 70.28 Million TWD in annual operating expenses 2022, up 46.29% from previous year.
  • TFBS Bioscience Inc. reported a annual operating expenses of 48.04 Million TWD in annual operating expenses 2021, up 40.21% from previous year.
  • TFBS Bioscience Inc. reported a quarterly operating expenses of 70.28 Million TWD for 2022 FY, up 46.29% from previous quarter.
  • TFBS Bioscience Inc. reported a quarterly operating expenses of 48.04 Million TWD for 2021 FY, up 40.21% from previous quarter.

Annual Operating Expenses Chart of TFBS Bioscience Inc. (2023 - 2020)

Historical Annual Operating Expenses of TFBS Bioscience Inc. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 77.82 Million TWD 17.08%
2022 70.28 Million TWD 46.29%
2021 48.04 Million TWD 40.21%
2020 34.26 Million TWD 0.0%

Peer Operating Expenses Comparison of TFBS Bioscience Inc.

Name Operating Expenses Operating Expenses Difference
BIONET Corp. 553.58 Million TWD 85.941%
DIVA Laboratories, Ltd. 158.62 Million TWD 50.934%
Genetics Generation Advancement Corp. 218.25 Million TWD 64.34%
Welgene Biotech Co.,Ltd. 123.97 Million TWD 37.222%
Puriblood Medical Co., Ltd. 56.92 Million TWD -36.72%